Biomarker for prostate cancer
US-2025076301-A1 · Mar 6, 2025 · US
Prostate diseases, e.g. BPH, prostatitis
Prostate diseases, e.g. BPH, prostatitis · Cooperative Patent Classification (CPC)
Computing, optics, measurement, and control technologies.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | G01N2800/342 |
| Official title | Prostate diseases, e.g. BPH, prostatitis |
| Display label | Prostate diseases, e.g. BPH, prostatitis |
| Total patents | 40 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
PSMA targeted fluorescent agents for image guided surgery
US-12065413-B2 · Aug 20, 2024 · US
Methods for diagnosis and treatment of chronic prostatitis and/or chronic pelvic pain syndrome
US-2024230650-A1 · Jul 11, 2024 · US
Psma-targeting compounds and uses thereof
US-2023348405-A1 · Nov 2, 2023 · US
PSMA-targeting compounds and uses thereof
US-11661402-B2 · May 30, 2023 · US
Psma-targeting compounds and uses thereof
US-2022259161-A1 · Aug 18, 2022 · US
Psma targeted fluorescent agents for image guided surgery
US-2022048872-A1 · Feb 17, 2022 · US
Method and an apparatus for determining a presence or an amount of a polyamine or its derivative in a sample
US-11181501-B2 · Nov 23, 2021 · US
Diagnostic apparatus
US-11092580-B2 · Aug 17, 2021 · US
PSMA targeted fluorescent agents for image guided surgery
US-11021450-B2 · Jun 1, 2021 · US
Method for analyzing PSA and method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA
US-10866240-B2 · Dec 15, 2020 · US
Psma targeted fluorescent agents for image guided surgery
US-2020216402-A1 · Jul 9, 2020 · US
Diagnostic apparatus
US-2020200721-A1 · Jun 25, 2020 · US
Psma targeted fluorescent agents for image guided surgery
US-2020109124-A1 · Apr 9, 2020 · US
Method and an apparatus for determining a presence or an amount of a polyamine or its derivative in a sample
US-2020080960-A1 · Mar 12, 2020 · US
Methods for differentiating benign prostatic hyperplasia from prostate cancer
US-2020018758-A1 · Jan 16, 2020 · US
Method for discriminating between prostate cancer and a benign prostate disease
US-2019310257-A1 · Oct 10, 2019 · US
Method for discriminating between prostate cancer and a benign prostate disease
US-10371704-B2 · Aug 6, 2019 · US
System and method for detecting alpha-methylacyl-CoA racemase (AMACR) and prostate cancer
US-10246734-B2 · Apr 2, 2019 · US
Methods for discriminating between prostate cancer and a benign prostate-disease
US-10222385-B2 · Mar 5, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC G01N2800/342?
- CPC G01N2800/342 is the Cooperative Patent Classification code for “Prostate diseases, e.g. BPH, prostatitis.”
- How many patents are filed under CPC G01N2800/342 (Prostate diseases, e.g. BPH, prostatitis)?
- Our database includes 40 publications tagged with this CPC code.
- Is patent activity under CPC G01N2800/342 growing?
- Publication counts under this code: 2 in 2024 vs 1 in 2025 (latest complete years).